EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma

Hera Hasan iD, Mohammad Afzal iD, Javier S Castresana iD, Mehdi H Shahi iD

Cells · 2023

DOI: 10.3390/cells12121578 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Hera Hasan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Brain Research Centre, Faculty of Medicine, Aligarh Muslim University, Aligarh 202002, India. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Navarra Foundation, Pamplona, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is the most aggressive form of brain tumor originating from glial cells with a maximum life expectancy of 14.6 months. Despite the establishment of multiple promising therapies, the clinical outcome of glioblastoma patients is abysmal. Drug resistance has been identified as a major factor contributing to the failure of current multimodal therapy. Epigenetic modification, especially DNA methylation has been identified as a major regulatory mechanism behind glioblastoma progression. In addition, miRNAs, a class of non-coding RNA, have been found to play a role in the regulation as well as in the diagnosis of glioblastoma. The relationship between epigenetics, drug resistance, and glioblastoma progression has been clearly demonstrated. MGMT hypermethylation, leading to a lack of MGMT expression, is associated with a cytotoxic effect of TMZ in GBM, while resistance to TMZ frequently appears in MGMT non-methylated GBM. In this review, we will elaborate on known miRNAs linked to glioblastoma; their distinctive oncogenic or tumor suppressor roles; and how epigenetic modification of miRNAs, particularly via methylation, leads to their upregulation or downregulation in glioblastoma. Moreover, we will try to identify those miRNAs that might be potential regulators of MGMT expression and their role as predictors of tumor response to temozolomide treatment. Although we do not impact clinical data and survival, we open possible experimental approaches to treat GBM, although they should be further validated with clinically oriented studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicroRNAsHumansDacarbazineAntineoplastic Agents, AlkylatingDNA Repair EnzymesTumor Suppressor ProteinsDNA Modification MethylasesTemozolomideDNA MethylationEpigenesis, Genetic

Stichwörter der Autor:innen

DNA methylationepigeneticsglioblastomamiRNAtemozolomide

Substanzen

DacarbazineAntineoplastic Agents, AlkylatingMicroRNAsDNA Repair EnzymesTumor Suppressor ProteinsDNA Modification MethylasesTemozolomide

Autor:innen und Institutionen

  • Interdisciplinary Brain Research Centre, Faculty of Medicine, Aligarh Muslim University, Aligarh 202002, India.
  • Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202002, India.
  • Department of Biochemistry and Genetics, University of Navarra School of Sciences, 31008 Pamplona, Spain.

ORCID-Profile: Hera Hasan, Mohammad Afzal, Javier S Castresana, Mehdi H Shahi

Förderung

  • University of Navarra Foundation, Pamplona, Spain

Zitieren

APA

Hasan, H., Afzal, M., Castresana, J. S., & Shahi, M. H. (2023). A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma. Cells. https://doi.org/10.3390/cells12121578

Vancouver

Hasan H, Afzal M, Castresana JS, Shahi MH. A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma. Cells. 2023. doi:10.3390/cells12121578

BibTeX
@article{Hasan2023,
  author = {Hasan, Hera and Afzal, Mohammad and Castresana, Javier S and Shahi, Mehdi H},
  title = {A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12121578}
}
Kostenlos starten →